Comparison of Bowel Preparation in Virtual Colonoscopy (VC) - Patient Experience
NCT ID: NCT00460837
Last Updated: 2010-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
150 participants
INTERVENTIONAL
2007-11-30
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MOVIPREP® Versus PICOLAX® Pilot Study
NCT00312481
Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy
NCT02124447
Comparison Between Coolprep and Picolyte for Bowel Cleansing
NCT01774175
Investigation of PICOPREP and PEG-ELS for Bowel Preparation for Colonoscopy
NCT01356407
Patient Preference With Visicol Tablet Preparation for Colonoscopy
NCT00318305
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Unlike existing whole colon investigations (conventional colonoscopy and barium enema), reduced laxative regimens can be successfully used with VC, with the aim of improving patient experience, whilst maintaining diagnostic accuracy. These regimens utilize faecal tagging; a method of labeling residual faeces and fluid with radiodense liquids, such as iodine or barium based fluids, which are taken orally by the patient. Once faecal residue and fluid is labeled in this way, it can easily be discriminated from true pathology (which remains 'untagged').
We are proposing to compare different bowel preparation regimens, and ascertain patient experience of the different regimes, while monitoring diagnostic accuracy of the 2 different regiments.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 A
gastrofin \& Picolax
bowel preparation: senna & gastrofin versus picolax (standard)
The intervention is a bowel cleansing procedure
2
senna
bowel preparation: senna & gastrofin versus picolax (standard)
The intervention is a bowel cleansing procedure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bowel preparation: senna & gastrofin versus picolax (standard)
The intervention is a bowel cleansing procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* patients who take laxatives regularly or with previous inadequate colonic examination due to excessive faecal residue
* patients deemed too frail to undergo full bowel preparation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
London North West Healthcare NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
North West London Hospitals NHS Trust
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Burling
Role: PRINCIPAL_INVESTIGATOR
St Mark's Hospital, North West London Hospitals NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Mark's Hospital, North West London Hospitals NHS Trust
London, Middlesex, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07.senna.SMH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.